Heteroepitaxial Growth of B5 -Site-Rich Ru Nanoparticles Guided by Hexagonal Boron Nitride for Low-Temperature Ammonia Dehydrogenation

© 2022 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 35(2023), 4 vom: 23. Jan., Seite e2203364
1. Verfasser: Kang, Sungsu (VerfasserIn)
Weitere Verfasser: Cha, Junyoung, Jo, Young Suk, Lee, Yu-Jin, Sohn, Hyuntae, Kim, Younhwa, Song, Chyan Kyung, Kim, Yongmin, Lim, Dong-Hee, Park, Jungwon, Yoon, Chang Won
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article B5 site ammonia dehydrogenation catalysis hexagonal boron nitride ruthenium
Beschreibung
Zusammenfassung:© 2022 Wiley-VCH GmbH.
Ruthenium is one of the most active catalysts for ammonia dehydrogenation and is essential for the use of ammonia as a hydrogen storage material. The B5 -type site on the surface of ruthenium is expected to exhibit the highest catalytic activity for ammonia dehydrogenation, but the number of these sites is typically low. Here, a B5 -site-rich ruthenium catalyst is synthesized by exploiting the crystal symmetry of a hexagonal boron nitride support. In the prepared ruthenium catalyst, ruthenium nanoparticles are formed epitaxially on hexagonal boron nitride sheets with hexagonal planar morphologies, in which the B5 sites predominate along the nanoparticle edges. By activating the catalyst under the reaction condition, the population of B5 sites further increases as the facets of the ruthenium nanoparticles develop. The electron density of the Ru nanoparticles also increases during catalyst activation. The synthesized catalyst shows superior catalytic activity for ammonia dehydrogenation compared to previously reported catalysts. This work demonstrates that morphology control of a catalyst via support-driven heteroepitaxy can be exploited for synthesizing highly active heterogeneous catalysts with tailored atomic structures
Beschreibung:Date Completed 27.01.2023
Date Revised 02.02.2023
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202203364